Loading clinical trials...

Handheld Dynamometer During Awake Craniotomy Pilot | Clinical Trials | Clareo Health

COMPLETEDNA

Handheld Dynamometer During Awake Craniotomy Pilot

Use of Handheld Dynamometer As a Novel Tool to Assess Motor Function During Awake Craniotomy for Brain Lesions Located Within or Adjacent to the Motor Cortex: a Single-Center Pilot Study

NCT04742231•Mayo Clinic

View on ClinicalTrials.gov

Summary

The primary purpose of this study is to assess the feasibility, safety and reliability of the use of handheld dynamometry in evaluating intraoperative motor function for patients undergoing awake craniotomy for the resection of brain lesions located within or adjacent to the motor cortex.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients ≥ 18 years old.
•Primary or Recurrent Brain tumors
•Single brain lesion
•Lesion within or adjacent to the motor cortex- Lesion located within the primary or supplementary motor area (Verified by preoperative fMRI and DTI).

Exclusion Criteria

•Patients \< 18 years old.
•Major comorbidities (congestive heart failure, severe chronic obstructive pulmonary disease, morbid obesity, obstructive sleep apnea).
•Patients with cognitive, intellectual or psychiatric impairment that could affect the capacity of following instructions evaluated during preoperative neuropsychological testing.

Locations (1)

Mayo Clinic

Jacksonville, Florida, United States

Key Dates

Start Date

July 1, 2020

Primary Completion Date

June 25, 2024

Completion Date

June 25, 2024

Last Updated

March 4, 2025

Enrollment

ACTUAL participants

Conditions

Brain LesionBrain Tumor AdultBrain Tumor

Interventions

Hand-held dynamometer

DEVICE

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

High Grade GliomaDiffuse Intrinsic Pontine Glioma+7 more

View study

RECRUITINGNA

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

NCT06962215

Brain Tumor Adult

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Handheld Dynamometer During Awake Craniotomy Pilot

Inclusion Criteria

Exclusion Criteria

Targeted Pediatric High-Grade Glioma Therapy

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Top-Down Attentional Control of Visual-Processing

Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach